This qualitative study describes the process of building EVOLV-Rx (Evaluating Opportunities to Decrease Low-Value Prescribing) with a panel of clinicians, deprescribing experts, health care leaders, and other stakeholders. Click to show full abstract
This qualitative study describes the process of building EVOLV-Rx (Evaluating Opportunities to Decrease Low-Value Prescribing) with a panel of clinicians, deprescribing experts, health care leaders, and other stakeholders.
               
Click one of the above tabs to view related content.